Expert consensus statement on therapeutic drug monitoring and individualization of linezolid

Linezolid is an oxazolidinone antibacterial drug, and its therapeutic drug monitoring and individualized treatment have been challenged since its approval. With the in-depth clinical research of linezolid, we have changed our attitude toward its therapeutic drug monitoring and our view of individual...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Bin, Hu, Yangmin, Xu, Ping, Xu, Tao, Chen, Chunyan, He, Le, Zhou, Mi, Chen, Zhangzhang, Zhang, Chunhong, Yu, Xuben, Fang, Luo, Zhu, Junfeng, Ji, Yanlan, Lin, Qun, Cao, Hengbin, Dai, Youqin, Lu, Xiaoyan, Shi, Changcheng, Li, Li, Wang, Changjiang, Li, Xumei, Fang, Qiongyan, Miao, Jing, Zhu, Zhengyi, Lin, Guangyong, Zhan, Haichao, Lv, Shiwen, Zhu, Yalan, Cai, Xinjun, Ying, Yin, Chen, Meng, Xu, Qiong, Zhang, Yiwen, Xu, Yubin, Federico, Pea, Jiang, Saiping, Dai, Haibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399604/
https://www.ncbi.nlm.nih.gov/pubmed/36033811
http://dx.doi.org/10.3389/fpubh.2022.967311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399604/
https://www.ncbi.nlm.nih.gov/pubmed/36033811
http://dx.doi.org/10.3389/fpubh.2022.967311

Ejemplares similares